FindTrial
Sign In

The multi-center clinical research in TCM diagnosis and treatment norms on Rheumatoid arthritis of piweikuixu-shirezuluo symptoms

The multi-center clinical research in TCM diagnosis and treatment norms on Rheumatoid arthritis of piweikuixu-shirezuluo symptoms

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009274
Enrollment
Unknown
Registered
2016-09-25
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

RA No.1+fengshi mud:RA No.1+fengshi mud
MTX+LEF Group:MTX+LEF
RA No.1+fengshi mud+MTX+LEF Group:RA No.1+fengshi mud+MTX+LEF

Sponsors

Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patient with Rheumatoid arthritis and TCM 'zhen' piweikuixu-shirezuluo

Exclusion criteria

Exclusion criteria: Not meet the requirements of the subject

Design outcomes

Primary

MeasureTime frame
cAMP/cGMP;IFN-?mRNA, IL-4mRNA;joints BUS;joints MRI;—

Countries

China

Contacts

Public ContactSong Xinwei

Zhejiang Provincial Hospital of TCM

sxw1055@163.com+86 13805790791

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026